AtriCure, Inc. (ATRC) stock
ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30611% above fair value
$56.84+0.86 (+1.54%)
Close on Nov 13, 2026Market cap $2.89BP/E 189.5Yield –
AtriCure operating margin
Operating margin is operating income as a percentage of revenue.
AtriCure's operating margin for the twelve months ending Sep 30, 2026 was 2.9%. For fiscal 2025 it was -1.8%, against -8.6% the year before. The highest annual figure on record is 20.1% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1.8% | +6.8 |
| FY2024 | Dec 31, 2024 | -8.6% | −1.9 |
| FY2023 | Dec 31, 2023 | -6.7% | +6.2 |
| FY2022 | Dec 31, 2022 | -12.9% | −33.0 |
| FY2021 | Dec 31, 2021 | 20.1% | +41.5 |
| FY2020 | Dec 31, 2020 | -21.4% | −7.1 |
| FY2019 | Dec 31, 2019 | -14.4% | −5.9 |
| FY2018 | Dec 31, 2018 | -8.5% | +5.8 |
| FY2017 | Dec 31, 2017 | -14.3% | +5.8 |
| FY2016 | Dec 31, 2016 | -20.1% | +0.5 |
| FY2015 | Dec 31, 2015 | -20.6% | −5.4 |
| FY2014 | Dec 31, 2014 | -15.2% | −1.9 |
| FY2013 | Dec 31, 2013 | -13.3% | −3.1 |
| FY2012 | Dec 31, 2012 | -10.2% | −2.9 |
| FY2011 | Dec 31, 2011 | -7.3% | −1.9 |
| FY2010 | Dec 31, 2010 | -5.4% | +23.0 |
| FY2009 | Dec 31, 2009 | -28.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 2.8% | +2.7 |
| Q2 FY2026 | Jun 30, 2026 | 6.3% | +10.8 |
| Q1 FY2026 | Mar 31, 2026 | 0.4% | +5.2 |
| Q4 FY2025 | Dec 31, 2025 | 1.8% | +13.5 |
| Q3 FY2025 | Sep 30, 2025 | 0.2% | +6.5 |
| Q2 FY2025 | Jun 30, 2025 | -4.5% | +1.6 |
| Q1 FY2025 | Mar 31, 2025 | -4.8% | +5.2 |
| Q4 FY2024 | Dec 31, 2024 | -11.7% | −3.6 |
| Q3 FY2024 | Sep 30, 2024 | -6.4% | +1.8 |
| Q2 FY2024 | Jun 30, 2024 | -6.2% | −2.1 |
| Q1 FY2024 | Mar 31, 2024 | -10.0% | −3.8 |
| Q4 FY2023 | Dec 31, 2023 | -8.1% | −3.4 |
| Q3 FY2023 | Sep 30, 2023 | -8.2% | +4.7 |
| Q2 FY2023 | Jun 30, 2023 | -4.1% | +12.1 |
| Q1 FY2023 | Mar 31, 2023 | -6.2% | +12.8 |
| Q4 FY2022 | Dec 31, 2022 | -4.7% | +12.4 |
| Q3 FY2022 | Sep 30, 2022 | -12.9% | −152.9 |
| Q2 FY2022 | Jun 30, 2022 | -16.2% | +5.0 |
| Q1 FY2022 | Mar 31, 2022 | -19.0% | +7.8 |
| Q4 FY2021 | Dec 31, 2021 | -17.1% | +13.2 |
| Q3 FY2021 | Sep 30, 2021 | 140.0% | +147.3 |
| Q2 FY2021 | Jun 30, 2021 | -21.1% | −3.3 |
| Q1 FY2021 | Mar 31, 2021 | -26.8% | +2.2 |
| Q4 FY2020 | Dec 31, 2020 | -30.3% | −5.3 |
| Q3 FY2020 | Sep 30, 2020 | -7.3% | +8.0 |
| Q2 FY2020 | Jun 30, 2020 | -17.8% | −11.3 |
| Q1 FY2020 | Mar 31, 2020 | -29.0% | −19.2 |
| Q4 FY2019 | Dec 31, 2019 | -25.0% | −20.1 |
| Q3 FY2019 | Sep 30, 2019 | -15.3% | −3.1 |
| Q2 FY2019 | Jun 30, 2019 | -6.5% | −8.4 |
| Q1 FY2019 | Mar 31, 2019 | -9.9% | +10.2 |
| Q4 FY2018 | Dec 31, 2018 | -4.9% | −0.3 |
| Q3 FY2018 | Sep 30, 2018 | -12.1% | +4.1 |
| Q2 FY2018 | Jun 30, 2018 | 1.8% | +15.9 |
| Q1 FY2018 | Mar 31, 2018 | -20.1% | +3.3 |
| Q4 FY2017 | Dec 31, 2017 | -4.6% | +14.1 |
| Q3 FY2017 | Sep 30, 2017 | -16.2% | – |
| Q2 FY2017 | Jun 30, 2017 | -14.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -23.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -18.7% | – |
See a number that looks wrong?